Chemical Structure (Levophed 01)
Levophed Injection, Solution, Concentrate
Product Images NDC 0409-0161
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levophed (NDC 0409-0161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Levophed 02)
Principal Display Panel (4 mL Vial Label)
This is a description of a medication vial containing norepinephrine bitartrate solution for intravenous infusion. The vial is single-dose and has a flip-top cap. The concentration is 4 mg per 4 mL (1 mg/mL). The label warns that it contains sulfites. This medication is distributed by Hospira Inc. It is available by prescription only with the National Drug Code (NDC) 0403-0761-01.*
Principal Display Panel (4 mL Vial Carton)
This is a description for Levophed (norepinephrine bitartrate) injection, USP in 4 mg/4 mL single-dose vials. The vials are sterile and meant for injection purposes. Each vial contains a concentrated solution with a strength of 1 mg/mL. The product should be used before the expiration date and any unused portion should be discarded. It is recommended to protect the vials from light exposure. The drug is available by prescription only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
